4//SEC Filing
BIOS Fund II NT, LP 4
Accession 0001104659-24-089821
CIK 0001652935other
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 8:46 PM ET
Size
27.1 KB
Accession
0001104659-24-089821
Insider Transaction Report
Form 4
Cavu Management, LP
Director10% Owner
Holdings
- 60,973(indirect: Directly held by Aaron G.L. Fletcher)
Common Stock
- 8,056(indirect: By Trust)
Common Stock
- 8,056(indirect: By Trust)
Common Stock
- 69,375(indirect: Directly held by Circle K Invesco, LP)
Common Stock
- 84,917(indirect: Directly held by BP Directors, LP)
Common Stock
BIOS Fund I, LP
Director10% Owner
Holdings
- 8,056(indirect: By Trust)
Common Stock
- 69,375(indirect: Directly held by Circle K Invesco, LP)
Common Stock
- 84,917(indirect: Directly held by BP Directors, LP)
Common Stock
- 8,056(indirect: By Trust)
Common Stock
- 60,973(indirect: Directly held by Aaron G.L. Fletcher)
Common Stock
BIOS Fund II NT, LP
Director10% Owner
Holdings
- 8,056(indirect: By Trust)
Common Stock
- 84,917(indirect: Directly held by BP Directors, LP)
Common Stock
- 69,375(indirect: Directly held by Circle K Invesco, LP)
Common Stock
- 60,973(indirect: Directly held by Aaron G.L. Fletcher)
Common Stock
- 8,056(indirect: By Trust)
Common Stock
BIOS Fund II QP, LP
Director10% Owner
Holdings
- 8,056(indirect: By Trust)
Common Stock
- 60,973(indirect: Directly held by Aaron G.L. Fletcher)
Common Stock
- 84,917(indirect: Directly held by BP Directors, LP)
Common Stock
- 69,375(indirect: Directly held by Circle K Invesco, LP)
Common Stock
- 8,056(indirect: By Trust)
Common Stock
Cavu Advisors, LLC
Director10% Owner
Holdings
- 60,973(indirect: Directly held by Aaron G.L. Fletcher)
Common Stock
- 8,056(indirect: By Trust)
Common Stock
- 69,375(indirect: Directly held by Circle K Invesco, LP)
Common Stock
- 84,917(indirect: Directly held by BP Directors, LP)
Common Stock
- 8,056(indirect: By Trust)
Common Stock
BIOS Fund I QP, LP
Director10% Owner
Holdings
- 69,375(indirect: Directly held by Circle K Invesco, LP)
Common Stock
- 60,973(indirect: Directly held by Aaron G.L. Fletcher)
Common Stock
- 8,056(indirect: By Trust)
Common Stock
- 8,056(indirect: By Trust)
Common Stock
- 84,917(indirect: Directly held by BP Directors, LP)
Common Stock
Bios Equity Partners, LP
Director10% Owner
Holdings
- 8,056(indirect: By Trust)
Common Stock
- 60,973(indirect: Directly held by Aaron G.L. Fletcher)
Common Stock
- 8,056(indirect: By Trust)
Common Stock
- 84,917(indirect: Directly held by BP Directors, LP)
Common Stock
- 69,375(indirect: Directly held by Circle K Invesco, LP)
Common Stock
Kreis Leslie W.
Director10% Owner
Holdings
- 84,917(indirect: Directly held by BP Directors, LP)
Common Stock
- 8,056(indirect: By Trust)
Common Stock
- 69,375(indirect: Directly held by Circle K Invesco, LP)
Common Stock
- 60,973(indirect: Directly held by Aaron G.L. Fletcher)
Common Stock
- 8,056(indirect: By Trust)
Common Stock
BIOS Fund II, LP
Director10% Owner
Holdings
- 8,056(indirect: By Trust)
Common Stock
- 8,056(indirect: By Trust)
Common Stock
- 69,375(indirect: Directly held by Circle K Invesco, LP)
Common Stock
- 84,917(indirect: Directly held by BP Directors, LP)
Common Stock
- 60,973(indirect: Directly held by Aaron G.L. Fletcher)
Common Stock
Bios Equity Partners II, LP
Director10% Owner
Holdings
- 60,973(indirect: Directly held by Aaron G.L. Fletcher)
Common Stock
- 8,056(indirect: By Trust)
Common Stock
- 84,917(indirect: Directly held by BP Directors, LP)
Common Stock
- 8,056(indirect: By Trust)
Common Stock
- 69,375(indirect: Directly held by Circle K Invesco, LP)
Common Stock
Footnotes (5)
- [F1]Bios Equity Partners, LP ("Bios Equity I") is the general partner of the following entities: Bios Fund I, LP ("Bios Fund I"), Bios Fund I QP, LP ("Bios Fund I QP") and BP Directors, LP ("BP Directors"). Bios Equity Partners II, LP ("Bios Equity II") is the general partner of Bios Fund II, LP ("Bios Fund II"), Bios Fund II QP, LP ("Bios Fund II QP"), Bios Fund II NT, LP ("Bios Fund II NT") and Bios Actuate Co-Invest I, LP ("Bios Actuate Co-Invest I"). Bios Equity Partners III, LP ("Bios Equity III") is the general partner of the following entities: Bios Fund III, LP ("Bios Fund III"), Bios Fund III QP, LP ("Bios Fund III QP"), Bios Fund III NT, LP ("Bios Fund III NT"), Bios Actuate Co-Invest II, LP ("Bios Actuate Co-Invest II") and Bios Actuate Co-Invest III, LP ("Bios Actuate Co-Invest III"). Bios Equity COF, LP ("Bios Equity COF") is the general partner of Bios Clinical Opportunity Fund, LP ("Bios COF") and Bios 2024 Co-Invest, LP ("Bios 2024 Co-Invest").
- [F2]Cavu Management, LP, an entity managed and controlled by Mr. Les Kreis, and Bios Capital Management, LP, an entity managed and controlled by Mr. Aaron Fletcher, are the general partners of Bios Equity I, Bios Equity II and Bios Equity III and Bios Capital Management, LP is the general partner of Bios Equity COF. Cavu Advisors LLC, an entity that is managed and controlled by Mr. Kreis, is the general partner of Cavu Management LP. Bios Advisors GP, LLC, an entity that is managed and controlled by Mr. Fletcher, is the general partner of Bios Capital Management, LP.
- [F3]The shares owned by Bios Fund I, Bios Fund I QP, BP Directors, Bios Fund II, Bios Fund II QP, Bios Fund II NT, Bios Actuate Co-Invest I, Bios Fund III, Bios Fund III QP, Bios Fund III NT, Bios Actuate Co-Invest II, Bios Actuate Co-Invest III, Bios COF and Bios 2024 Co-Invest (collectively, the "Bios Equity Entities") are aggregated for purposes of reporting share ownership information. Mr. Kreis and Mr. Fletcher have voting and investment control with respect to shares held indirectly by Bios Advisors GP, LLC and Cavu Advisors, LLC, respectively.
- [F4]Shares are held in a trust, which has an independent trustee, for the benefit of Mr. Fletcher's children. Mr. Fletcher disclaims beneficial ownership of such shares other than to the extent he may have a pecuniary interest therein.
- [F5]Shares are held by Circle K Invesco, LP, over which Mr. Kreis has sole voting and investment control.
Documents
Issuer
ACTUATE THERAPEUTICS, INC.
CIK 0001652935
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001728851
Filing Metadata
- Form type
- 4
- Filed
- Aug 13, 8:00 PM ET
- Accepted
- Aug 14, 8:46 PM ET
- Size
- 27.1 KB